Can Zhang
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Nanocomposite Films for Food Packaging
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 70
- Nanoparticle-Based Drug Delivery 52
-
- Advanced Drug Delivery Systems 19
Can Zhang
288 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Biomaterials 4.0k
- Pharmaceutical Science 1.1k
- Molecular Medicine 529
- Biomedical Engineering 3.5k
- Surfaces, Coatings and Films 368
Countries citing papers authored by Can Zhang
This map shows the geographic impact of Can Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Zhang more than expected).
Fields of papers citing papers by Can Zhang
This network shows the impact of papers produced by Can Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Zhang. The network helps show where Can Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Can Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 37 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 52 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 12 | |
| 17 | 2023 | 18 | |
| 18 | 2021 | 7 | |
| 19 | 2017 | 18 | |
| 20 | 2014 | 22 |
About Can Zhang
Can Zhang is a scholar working on Biomaterials, Pharmaceutical Science, Molecular Medicine, Immunology and Oncology, having authored 308 papers that have together received 10.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (52 papers), Nanoplatforms for cancer theranostics (33 papers), RNA Interference and Gene Delivery (33 papers), Advanced Drug Delivery Systems (19 papers), CAR-T cell therapy research (14 papers), Immune cells in cancer (14 papers), Advanced biosensing and bioanalysis techniques (12 papers) and Hydrogels: synthesis, properties, applications (11 papers). The work is most often cited by research in Biomaterials (4.0k citations), Pharmaceutical Science (1.1k citations), Molecular Medicine (529 citations), Biomedical Engineering (3.5k citations) and Surfaces, Coatings and Films (368 citations). Can Zhang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qineng Ping, Ran Mo, Lingjing Xue, Jingwei Xue, Caoyun Ju, Zhigui Su, Hongbin Sun, Ya Ding, Liangli Yu and Hongjuan Zhang. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Controlled Release, Carbohydrate Polymers, Biomaterials and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.